Pregnancy Outcomes After Exposure to Certolizumab Pegol-Reference-Cited by-同舟云学术

Pregnancy Outcomes After Exposure to Certolizumab Pegol

Published:2018-07-22 Issue:9 Volume:70 Page:1399-1407
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Clowse Megan E. B.¹,Scheuerle Angela E.²,Chambers Christina³,Afzali Anita⁴,Kimball Alexa B.⁵,Cush John J.⁶,Cooney Maureen⁷,Shaughnessy Laura⁷,Vanderkelen Mark⁸,Förger Frauke⁹

Affiliation:

1. Duke University Medical Center; Durham North Carolina

2. University of Texas Southwestern Medical Center; Dallas

3. University of California; La Jolla

4. The Ohio State University Wexner Medical Center; Columbus

5. Beth Israel Deaconess Medical Center and Harvard Medical School; Boston Massachusetts

6. Baylor Scott & White Research Institute; Dallas Texas

7. UCB Pharma; Raleigh North Carolina

8. UCB Pharma; Braine-l'Alleud Belgium

9. Inselspital; University of Bern; Bern Switzerland

Funder

UCB Pharma

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.40508/fullpdf

Reference45 articles.

1. Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases;Kavanaugh;Arthritis Care Res (Hoboken),2015

2. Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives;Chakravarty;BMJ Open,2014

3. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients;Van den Brandt;Arthritis Res Ther,2017

4. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom study of 209 pregnant women;Pedersen;Aliment Pharmacol Ther,2013

5. Inflammatory bowel disease and risk of adverse pregnancy outcomes;Boyd;PLoS One,2015

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures;Current Drug Safety;2024-11

2. A Review of Hidradenitis Suppurativa in Special Populations: Considerations in Children, Pregnant and Breastfeeding Women, and the Elderly;Dermatology and Therapy;2024-09

3. Management of Hidradenitis Suppurativa during Pregnancy and Lactation;Current Dermatology Reports;2024-08-22

4. Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis;Pharmaceuticals;2024-07-07

5. Real-life management of psoriasis with biological agents during pregnancy;Annales de Dermatologie et de Vénéréologie;2024-06